Related by context. Frequent words. (Click for all words.) 75 events AEs 73 Adverse events 72 nasopharyngitis 70 AEs 66 febrile neutropenia 66 leukopenia 66 infusion reactions 65 SAEs 65 composite endpoint 65 arthralgia 64 discontinuations 64 mg BID 63 pyrexia 63 patients receiving ERBITUX 61 asthenia 61 evaluable 61 thrombocytopenia 61 dose limiting toxicities 61 neutropenia 60 hypersensitivity reactions 60 mg dose 60 Adverse reactions 59 mucositis 59 limiting toxicity 59 placebo 59 myalgia 59 dyspnea 59 thromboembolism 58 ACTEMRA 58 pruritus 58 ≥ 58 quetiapine 58 certolizumab pegol 58 placebo p 57 Secondary endpoints 57 glimepiride 57 adverse reactions 57 secondary endpoint 57 nausea diarrhea 57 bosentan 57 Secondary endpoints included 57 hypotension 57 tiotropium 57 hepatotoxicity 57 somnolence 57 lamotrigine 56 renal impairment 56 nonsignificant 56 headache nausea 56 exacerbations 56 placebo p = 56 nausea fatigue 56 toxicities 56 myocardial infarction MI 56 LVEF 55 musculoskeletal pain 55 hypoglycemia 55 adalimumab 55 diarrhea nausea 55 FOLFOX 55 Discontinuation 55 HbA1c levels 55 hypoglycaemia 54 renal insufficiency 54 Tolerability 54 secondary endpoints 54 P = .# 54 vertebral fractures 54 pioglitazone 54 stable angina 54 ONGLYZA 54 demonstrated statistically significant 54 Secondary endpoints include 54 mitoxantrone 54 tricyclic antidepressants 54 aripiprazole 54 gastrointestinal GI 54 JANUVIA 54 primary efficacy endpoint 54 CIMZIA 53 fluconazole 53 VTE 53 mg doses 53 ARCALYST 53 TIMI 53 placebo controlled 53 confidence interval CI 53 ABILIFY 53 ORENCIA 53 pramipexole 53 telbivudine 53 levofloxacin 53 evaluable patients 53 phenytoin 53 enoxaparin 53 unfractionated heparin 53 olanzapine 53 vandetanib 53 etanercept 53 creatinine clearance 53 plaque psoriasis